| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,573,734 ) |
| | 2025 | 2025 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 4 | CDC | 4/2/2025 | $400,000 |
| | 2025 | 2025 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HL173248 | Phenotyping Net Immune State with MicroRNAs in Cardiac Transplantation | 000 | 1 | NIH | 3/4/2025 | $804,438 |
| | 2025 | 2025 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 28 | HRSA | 4/28/2025 | $150,945 |
| | 2025 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R21GM150136 | The Scientific Value of Premature Infant Biospecimens Collection | 004 | 3 | NIH | 4/2/2025 | $11,454 |
| | 2025 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 4 | CDC | 4/2/2025 | $0 |
| | 2025 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R21GM150136 | The Scientific Value of Premature Infant Biospecimens Collection | 001 | 3 | NIH | 11/28/2024 | $206,897 |
| | 2025 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 000 | 5 | FDA | 1/31/2025 | $0 |
| | 2025 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R13HD113341 | Defining Research and Care in Diabetes in Pregnancy | 000 | 1 | NIH | 11/27/2024 | $0 |
| | 2025 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 4 | CDC | 4/2/2025 | $0 |
| | 2025 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 4 | CDC | 4/2/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,568,907 ) |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 12 | HRSA | 9/7/2024 | $0 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 02 | 27 | HRSA | 6/5/2024 | $438,152 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HD110109 | OPTIMUM OB-TXA: Optimal TIMing, route and dose of tranexamic acid prior to UMbilical cord clamp for postpartum hemorrhage prevention | 003 | 3 | NIH | 7/29/2024 | $556,408 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL153771 | Frailty and Resiliency in Older Adults with Acute Myocardial Infarction | 000 | 5 | NIH | 7/1/2024 | $183,120 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL143179 | MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | 000 | 5 | NIH | 7/18/2024 | $184,680 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 12 | HRSA | 7/1/2024 | $585,866 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 4 | CDC | 5/28/2024 | $441,625 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 01 | 27 | HRSA | 5/15/2024 | $0 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 03 | 27 | HRSA | 8/6/2024 | $11,987 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 3 | CDC | 2/29/2024 | $400,000 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 27 | HRSA | 3/13/2024 | $146,049 |
| | 2024 | 2024 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 000 | 5 | FDA | 6/6/2024 | $50,000 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HD110109 | OPTIMUM OB-TXA: Optimal TIMing, route and dose of tranexamic acid prior to UMbilical cord clamp for postpartum hemorrhage prevention | 001 | 2 | NIH | 1/3/2024 | $571,020 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HD110109 | OPTIMUM OB-TXA: Optimal TIMing, route and dose of tranexamic acid prior to UMbilical cord clamp for postpartum hemorrhage prevention | 002 | 2 | NIH | 3/7/2024 | $0 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 000 | 4 | NIH | 9/5/2024 | $0 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 4 | CDC | 5/28/2024 | $0 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 02 | 3 | CDC | 3/22/2024 | $0 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 3 | CDC | 2/8/2024 | $0 |
| | 2024 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 3 | CDC | 2/29/2024 | $0 |
| | 2024 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 3 | CDC | 2/8/2024 | $0 |
| | 2024 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 02 | 3 | CDC | 3/22/2024 | $0 |
| | 2024 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 3 | CDC | 2/29/2024 | $0 |
| | 2024 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 4 | CDC | 5/28/2024 | $0 |
| | 2024 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 01 | 3 | CDC | 2/8/2024 | $0 |
| | 2024 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 02 | 3 | CDC | 3/22/2024 | $0 |
| | 2024 | 2021 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 4 | CDC | 5/28/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,603,484 ) (Continued on the next page) |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL143179 | MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | 000 | 4 | NIH | 6/16/2023 | $184,680 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 00 | 11 | HRSA | 7/3/2023 | $585,866 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | K23HL153771 | Frailty and Resiliency in Older Adults with Acute Myocardial Infarction | 000 | 4 | NIH | 7/24/2023 | $183,120 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R01HL154768 | The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization | 000 | 4 | NIH | 9/1/2023 | $387,840 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU62PS924691 | Strategic partnerships in Northern Virginia to increase HIV diagnosis,treatment, prevention, and response among high-risk heterosexual Black, Latinx, and immigrant identified populations | 00 | 3 | CDC | 6/2/2023 | $441,625 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R13HD113341 | Defining Research and Care in Diabetes in Pregnancy | 000 | 1 | NIH | 8/14/2023 | $10,000 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | H7600177 | OP EARLY INTERVENTION SVCS W/RESPECT TO HIV DISEASE | 00 | 26 | HRSA | 3/15/2023 | $584,201 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8110 Gatehouse Rd Ste 200e | Falls Church | VA | 22042-1210 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 00 | 2 | CDC | 3/3/2023 | $400,000 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | NU65PS923739 | Comprehensive High-Impact HIV Prevention Program for Young Men of Color Who Have Sex with Men | 01 | 2 | CDC | 6/1/2023 | $0 |
| | 2023 | 2023 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22031-4868 | FAIRFAX | USA | R18FD006920 | The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community | 001 | 4 | FDA | 4/5/2023 | $0 |
| | 2023 | 2022 | INOVA HEALTH CARE SERVICES | 8095 INNOVATION PARK DR | FAIRFAX | VA | 22042-4868 | | USA | H1224873 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 10 | HRSA | 10/24/2022 | $0 |
|
